At the molecular level, Iqgap2 −/− HCC tumors were characterized by an 8-fold increase in cyclin D1 levels (a β-catenin nuclear target), a 9-fold upregulation of cytoplasmic IQGAP1 expression and loss of membrane E-cadherin expression. This evidence concerns the gene IQGAP2 and hepatocellular carcinoma.